GoKawiilScience Corp's Max Hodak to preview brain-computer interface trials at TechCrunch Disrupt 2026
Science Corporation CEO Max Hodak will speak at TechCrunch Disrupt 2026's Beyond Screens session about his company's biohybrid brain-computer interface, for which it has recruited a leading neurobiologist to run the first U.S. human trials. Hodak, a Neuralink co-founder, argues that keyboards and screens will eventually give way to interfaces built directly around brain activity.